DR YASSER A SALLAM RECECNT PUBLICATIONS

Citation:
, DR YASSER A SALLAM RECECNT PUBLICATIONS, , Submitted.
PUBLICATIONS:

 

 

Top of Form

1. Response Criteria to Induction Chemotherapy as a Prognostic Factor for Adult Acute Myeloid Leukemia

(Vol. 82, June 2014)

Response Criteria to Induction Chemotherapy as a Prognostic Factor for Adult Acute Myeloid Leukemia, NASR M. ALLAHLOUBI, 

YASSER

 A. 

SALLAM

, YAHIA M. ISMAIL and AHMED M.M. AL-DEBAWY   Abstract Background: ...

Created on 19 October 2014

2. Treatment Outcomes of Active Multiple Myeloma in Two Egyptian Oncology Centers

(Vol. 82, June 2014)

Treatment Outcomes of Active Multiple Myeloma in Two Egyptian Oncology Centers, NASR M.A. ALLAHLOUBI, ALFRED E. NAMOUR, 

YASSER

 A. 

SALLAM

, MOSAAD EL GAMMAL, FOUAD M. ABU-TALEB and 

YASSER

 A. MOHAMMED   ...

Created on 19 October 2014

3. Activating Mutation of D835 within the Activation Loop of FLT3 in Egyptian Patients with De Novo Acute Myeloid Leukemia with Low or Intermediate Risk Karyotypes are Associated with Poor Disease-Free Survival

(Vol. 82, March 2014)

... 

YASSER

 A. 

SALLAM

, ESSAM H. ELNOSHOKATY, FARIDA H. GADALLAH and SHEREN I. SALEM   Abstract Background: AML accounts for approximately 41.5% (349) out of the 840 newly diagnosed cases with acute leukemia ...

Created on 18 October 2014

4. Treatment Outcomes of Gastric Carcinoma: Experience of a Single Egyptian Cancer Center

(Vol. 82, March 2014)

Treatment Outcomes of Gastric Carcinoma: Experience of a Single Egyptian Cancer Center, AHMED A. ZEENELDIN, HANAN R. NASSAR, MOSAAD M. EL-GAMMAL, 

YASSER

 A.

SALLAM

 and DINA S. AL-GAMAL   Abstract ...

Created on 18 October 2014

5. The Changing Patterns of Bilharzial Bladder Cancer and its Treatment Outcome, NCI, Cairo University Experience

(Vol. 77, March 2009)

The Changing Patterns of Bilharzial Bladder Cancer and its Treatment Outcome, NCI, Cairo University Experience,

YASSER

 A. 

SALLAM

, HOSSAM HUSSIEN, MOHAMAD EZZAT EL SAYED and HISHAM EL HUSIENY   Abstract ...

Created on 03 April 2013

6. Improvement in Systemic Chemotherapy Options for Advanced Cases of Bilharzial Bladder Cancer

(Vol. 77, June 2009)

Improvement in Systemic Chemotherapy Options for Advanced Cases of Bilharzial Bladder Cancer,

YASSER

 A. 

SALLAM

, ZIKRI K. ZIKRI, MAMDOUH EL-SHERBINY and AYMAN A. GABER   Abstract Bilharzial bladder ...

Created on 03 April 2013

7. Prognostic Impact of Internal Tandem Duplications in the Juxtamembrane Domain of FMSLike Tyrosine Kinase 3 Gene (FLT3-ITDs) in Patients with De Novo Acute Myeloid Leukemia with Favorable Karyotypes (Vol. 77, June 2009)

Prognostic Impact of Internal Tandem Duplications in the Juxtamembrane Domain of FMSLike Tyrosine Kinase 3 Gene (FLT3-ITDs) in Patients with De Novo Acute Myeloid Leukemia with Favorable Karyotypes,

YASSER

 ...

Created on 03 April 2013

 

 

8-Safety and efficacy of cetuximab-chemotherapy combination in Saudi patients with metastatic colorectal cancer,

Aboelkhair M Al-Gahmi1, Yasser A Bahadur2, Ehab E Fawzi2, Ezzeldin M Ibrahim1, Yasser A Sallam1, Ahmed A Zeeneldin,Indian Journal of Cancer, Vol. 44, No. 2, April-June, 2007, pp. 56-61

 

9- Impact of new agents on the outcome of patients with Impact of New Chemotherapeutic agents...R Gaafar, Y A Sallam, H E Shafik, F A Aboulkassem, M Emara, H Khaled,gulf journal of oncology, The 07/2014;

 

10-The prognostic significance of ki67 nuclear proliferation antigen and p53 tumour suppressor gene overexpression in aggressive B-cell lymphoma

Yasser A Sallam

,

Hanan R Nassar

,,Ahmed A Zeeneldin,

Ayman A Gaber

,Amany Helal ,Wael Tharwat

The Medical journal of Cairo University 01/2010;

 

11-Prognostic value of serum vascular endothelial growth factor in Egyptian females with metastatic triple negative breast cancer.

 

Fatma M Taha

,

Ahmed A Zeeneldin

,

Amani M Helal

,Ayman A Gaber ,

Yasser A Sallam

,

Hanan Ramadan

,

Manar M Moneer

,Medical Biochemistry Department, Faculty of Medicine, Cairo University, Egypt. Clinical biochemistry  08/2009; 42(13-14):1420-6. DOI: 10.1016/j.clinbiochem.2009.06.022 Source: 

PubMed

12- Prognostic value of performance status (PS) in advanced non-small cell lung cancer (NSCLC) patients receiving gemcitabine and cisplatin

 

R. Gaafar

,

Y. Sallam

,

H. Khaled

,

O. Mansour

,  

N. Abdel-Karim

,

I. El-Attar

Lung Cancer (Impact Factor: 3.39). 07/2005; 49. DOI: 10.1016/S0169-5002(05)81514-4

 13-Pemetrexed alone or in combination with cisplatin in the treatment of patients with advanced malignant mesothelioma: An open-label trial of the National Cancer Institute of Egypt

 

R. Gaafar

,

Y. Sallam

,

H. Khaled

,

G. Rizk

,

M. Emara

,

F. Abou El-Kasem

,

N. Ali El-Din

,

A. Abou-Rabia

,

M. Helal

,

N. Mokhtar

Lung Cancer 01/2005; 49. DOI: 10.1016/S0169-5002(05)80892-X

 

 

 

 

PreviewAttachmentSize
dr_yasser_sallam_recentpublication1.pdf260.37 KB
Tourism